Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Risk of nocardial infections with anti-tumor necrosis factor therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Risk of nocardial infections with anti-tumor necrosis factor therapy.
Risk of nocardial infections with anti-tumor necrosis factor therapy. Am J Med Sci. 2013 Aug; 346(2):166-8.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal
Humans
Humans
Immunosuppressive Agents
Immunosuppressive Agents
Infliximab
Infliximab
Male
Male
Middle Aged
Middle Aged
Nocardia
Nocardia
Nocardia Infections
Nocardia Infections
Tumor Necrosis Factor-alpha
Tumor Necrosis Factor-alpha
authors with profiles
Michael Stuart Bronze